Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

GXO and Hasbro Open Flagship U.S. Distribution Center

March 19, 2026

Breeze Wellbeing Launches “Insights” Feature to Address Workplace Loneliness

March 19, 2026

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

March 19, 2026

Shoppers president met health minister as Ontario expanded prescription powers

March 19, 2026

NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio’s Parkinson’s Disease Clinical Trial

March 19, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Global Menopausal Hot Flashes Market: Growth in Non-Hormonal Treatments and use of Online Pharmacies
Press Release

Global Menopausal Hot Flashes Market: Growth in Non-Hormonal Treatments and use of Online Pharmacies

By News RoomJanuary 5, 20242 Mins Read
Global Menopausal Hot Flashes Market: Growth in Non-Hormonal Treatments and use of Online Pharmacies
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) — The “Global Menopausal Hot Flashes Market by Treatment Type (Alternative Treatment, Hormonal Treatment, Non-Hormonal Treatment), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) – Forecast 2023-2030” report has been added to ResearchAndMarkets.com’s offering.

The Menopausal Hot Flashes Market size was estimated at USD 7.83 billion in 2022, USD 8.24 billion in 2023, growing at a CAGR of 6.06% to reach USD 12.54 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Menopausal Hot Flashes Market.

  • Based on Treatment Type, the market is studied across Alternative Treatment, Hormonal Treatment, and Non-Hormonal Treatment. The Alternative Treatment is is further studied across Black Cohosh, Herbal Medicines, and Vitamin E. The Hormonal Treatment is is further studied across Estrogen, Estrogen-Progesterone Combination, and Progesterone. The Non-Hormonal Treatment is projected to witness significant market share during forecast period.
  • Based on Distribution Channel, the market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Online Pharmacies is projected to witness significant market share during forecast period.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. Key Attributes:
Report Attribute Details
No. of Pages 197
Forecast Period 2023 – 2030
Estimated Market Value (USD) in 2023 $8.24 Billion
Forecasted Market Value (USD) by 2030 $12.54 Billion
Compound Annual Growth Rate 6.0%
Regions Covered Global

Companies Mentioned

  • A.Vogel Ltd.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Fervent Pharmaceuticals, LLC
  • Glenmark Pharmaceuticals Ltd.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.
  • TherapeuticsMD, Inc.
  • Zywie Ventures Private Limited

For more information about this report visit https://www.researchandmarkets.com/r/9wmabe

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Menopausal Hot Flashes Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

GXO and Hasbro Open Flagship U.S. Distribution Center

Breeze Wellbeing Launches “Insights” Feature to Address Workplace Loneliness

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio’s Parkinson’s Disease Clinical Trial

Media Tour : Discover the New Terminal

VR Receives NOI Drill Permit for its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada

Cris & the Crew Adventures Announces Launching of Experiences and Local Partnerships in Tenerife

Pizza Hut Invites Canada’s Bandwagon Fans to the Playoff Watch Party

Toobit Rolls Out AI Agent Trade Kit, Bridging AI Conversations with Market Actions

Editors Picks

Breeze Wellbeing Launches “Insights” Feature to Address Workplace Loneliness

March 19, 2026

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

March 19, 2026

Shoppers president met health minister as Ontario expanded prescription powers

March 19, 2026

NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio’s Parkinson’s Disease Clinical Trial

March 19, 2026

Latest News

Media Tour : Discover the New Terminal

March 19, 2026

VR Receives NOI Drill Permit for its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada

March 19, 2026

Cris & the Crew Adventures Announces Launching of Experiences and Local Partnerships in Tenerife

March 19, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version